Articles from IFF

IFF (NYSEIFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on April 11, 2025 to shareholders of record as of March 21, 2025.

IFF (NYSEIFF) today unveiled plans to expand its Cedar Rapids, Iowa facility to capture a larger share of the booming healthy snacks market both in the U.S. and globally. The 47,000-square-foot expansion represents a nearly $70 million investment. When fully operational in the latter half of 2026, the expansion is projected to create up to 40 new jobs.

IFF (NYSEIFF) announced changes to its executive leadership team, aligned with the Company’s external reporting structure.

International Flavors & Fragrances Inc. (NYSEIFF) reported financial results for the fourth quarter and full year ended December 31, 2024.

IFF (NYSEIFF) today announced that it will release its fourth quarter and full year 2024 earnings results following the market close on Tuesday, Feb. 18, 2025. The management team will host a live webcast on Wednesday, Feb. 19, 2025, at 9:00 a.m. ET to discuss results and outlook with the investor community.

IFF (NYSEIFF) today unveiled the next phase in the evolution of its Board of Directors, aimed at bolstering the company's long-term strategic vision and driving profitable market share growth.

IFF (NYSEIFF) today announced that Michael DeVeau—currently Senior Vice President, Corporate Finance and Investor Relations at IFF—has been named the company’s Executive Vice President and Chief Financial Officer, effective Jan. 1, 2025. DeVeau will succeed current CFO and Business Transformation Officer Glenn Richter, whose previously announced planned retirement will take effect at the end of 2024.

IFF (NYSEIFF) reported financial results for the third quarter ended September 30, 2024.

IFF (NYSEIFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on January 8, 2025 to shareholders of record as of December 20, 2024.

IFF (NYSEIFF) today announced that it will release its third quarter 2024 earnings results following the market close on Tuesday, Nov. 5, 2024. The management team will host a live webcast on Wednesday, Nov. 6, 2024 at 9:00 a.m. ET to discuss results and outlook with the investor community.

IFF (NYSEIFF) today announced that Chief Executive Officer Erik Fyrwald will participate in a fireside chat at the Barclays Global Consumer Staples Conference on Thursday, Sept. 5, 2024 at 1:30 p.m. ET.

IFF (NYSEIFF) reported financial results for the second quarter ended June 30, 2024.

IFF (NYSEIFF), a global leader in food and beverage, home and personal care, scent, and health—today announced that it aims to complete the renovation and expansion of its facilities in Shanghai Hongqiao Airport Business Park, Shanghai, China. The site will be fully operational by the end of August 2024. The 16,000 square-meter site, named “Shanghai Creative Center,” is IFF’s largest in Asia. The project is designed to drive the development of innovative solutions across the IFF portfolio in China and the Greater Asia market, further strengthening its global leadership in fragrances, flavors, functional ingredients, and bioscience-based portfolios.

IFF (NYSEIFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on October 9, 2024 to shareholders of record as of September 20, 2024.

IFF (NYSEIFF) today announced that it will release its second quarter 2024 earnings results following the market close on Tuesday, August 6, 2024. The management team will host a live webcast on Wednesday, August 7, 2024 at 9:00 a.m. ET to discuss results and outlook with the investor community.

IFF (NYSEIFF) today announced the appointment of Margarita Paláu-Hernández to its Board of Directors, effective June 3, 2024. Paláu-Hernández joins as a mutually agreed independent Director in connection with IFF’s previously disclosed cooperation agreement with Icahn Capital LP and its affiliates. Following the appointment of Paláu-Hernández, the Board will be comprised of 11 members, ten of which are independent.

IFF (NYSEIFF) today released its 2023 Do More Good Report, describing how the Company is progressing against its environmental, social, governance, and sustainable solutions (or ESG+) strategy across the organization. The report showcases that IFF enabled customers and consumers to avoid approximately 24.6 million tonnes of CO2e emissions using IFF innovations, amongst other achievements. The new report can be experienced by visiting iff.com/domoregoodreport.

IFF (NYSEIFF) today announced that Glenn Richter, IFF’s Chief Financial and Business Transformation Officer, plans to retire Dec. 31, 2024 after a three-year tenure with the company. A succession process has been initiated to evaluate internal and external candidates to succeed Richter as CFO.

IFF (NYSEIFF) reported financial results for the first quarter ended March 31, 2024.

IFF (NYSEIFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.40 per share of its common stock, payable on July 10, 2024 to shareholders of record as of June 21, 2024.

IFF (NYSEIFF) today announced that it will release its first quarter 2024 earnings results following the market close on Monday, May 6, 2024. The management team will host a live webcast on Tuesday, May 7, 2024 at 9:00 a.m. ET to discuss results and outlook with the investor community.

IFF (NYSEIFF) today announced that it has completed the previously announced divestiture of its Cosmetic Ingredients business to Clariant, a sustainably focused specialty chemicals company. As a part of Clariant, the business will continue to deliver innovative ingredients for the cosmetic and personal care product portfolio.

IFF (NYSEIFF) today announced Ana Paula Mendonça—who has dedicated her career to the advancement and commercialization of fragrance—has been named President of Scent, IFF, effective April 1. Simon Herriott, current president of Health & Biosciences and Scent will continue to lead IFF’s Health and Biosciences business unit.

IFF (NYSEIFF) today announced that it has entered into a definitive agreement to sell its Pharma Solutions business unit to French leader of plant-based ingredients Roquette for an enterprise value of up to $2.85 billion, which represents an enterprise value to EBITDA multiple of approximately 13x. IFF’s Pharma Solutions business is a well-established developer and manufacturer of pharmaceutical excipients and includes its Global Specialty Solutions business supporting industrial and methyl cellulosic food applications. The Pharma Solutions business being sold to Roquette is primarily made up of businesses within IFF’s existing Pharma Solutions division, with some adjustments to the perimeter of the transaction designed to align customers, businesses and the manufacturing footprint.

IFF (NYSEIFF) today announced that it will release its fourth quarter and full year 2023 earnings results following the market close on Tuesday, Feb. 20, 2024. The management team will host a live webcast on Wednesday, Feb. 21, 2024 at 9:00 a.m. ET to discuss results and outlook with the investor community.

IFF (NYSEIFF), a global leader in food and beverage, home and personal care and health, today announced its partnership with environmental non-governmental organization (NGO) Bellona in a long-term project to restore seaweed forests in northern Norway. The collaboration on the Norwegian Marine Restoration (NoMaRe) project aims to restore 5,000 square kilometers of seaweed forest by managing invasive sea urchin predation. The regrowth of the forests could increase biological carbon sequestration by 12 million tons – the equivalent of Norway’s total oil and gas industry emissions in 2021. The launch event held in Norway was attended by Andreas Bjelland Eriksen, Norway’s Minister of Climate and Environment, as well as senior members of the research community.

IFF (NYSEIFF) reported financial results for the third quarter ended September 30, 2023.

IFF (NYSEIFF) today announced the continuation of the cooperation agreement with Icahn Capital LP and its affiliates. Icahn Capital and IFF have agreed to renominate one Icahn director and one mutually agreed director to the IFF board for the 2024 proxy season.

IFF (NYSEIFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.81 per share of its common stock, payable on January 8, 2024 to shareholders of record as of December 28, 2023.

IFF (NYSEIFF) today announced that it will release its third quarter 2023 earnings results following the market close on Monday, Nov. 6, 2023. The management team will host a live webcast on Tuesday, Nov. 7, 2023 at 9:00 a.m. ET to discuss results and outlook with the investor community.

IFF (NYSEIFF) today announced that Chief Executive Officer Frank Clyburn will participate in a fireside chat at the Barclays Global Consumer Staples Conference on Thursday, Sept. 7, 2023 at 9:00 a.m. ET.

IFF (NYSEIFF) reported financial results for the second quarter ended June 30, 2023.

IFF (NYSEIFF) today announces that Dr. Gregory Yep, Chief R&D and Sustainability Officer, has resigned effective Sept. 1 to pursue a new opportunity in his professional journey. Yep will be succeeded by Dr. Casper Vroemen—Vice President of R&D, Health & Biosciences—who has dedicated his career to the advancement and commercialization of leading-edge biotechnology. Vroemen will be based in Union Beach, New Jersey, and will become part of IFF’s Executive Leadership Team.

IFF (NYSEIFF) today announced that it successfully completed the previously announced divestiture of its Flavor Specialty Ingredients (FSI) business to Exponent, a leading UK-based private equity firm, on August 1, 2023.

IFF (NYSEIFF) today announced that it will release its second quarter 2023 earnings results following the market close on Monday, August 7, 2023. The management team will host a live webcast on Tuesday, August 8, 2023 at 9:00 a.m. ET to discuss results and outlook with the investor community.

IFF (NYSEIFF) today announced that Yuvraj Arora, currently President, U.S. Categories for Kellogg North America, will join IFF as President, Nourish, effective June 19, 2023. Arora brings more than 25 years of multinational CPG experience to IFF’s Executive Leadership Team, mostly recently leading Kellogg’s $7 billion U.S. portfolio through a period of strong growth and portfolio transformation.

IFF (NYSEIFF) today announced that it has successfully completed the previously announced divestiture of its Savory Solutions business unit to PAI Partners (PAI), a leading global private equity firm with a strong focus on the food and consumer industry.

IFF (NYSEIFF) today released its 2022 Do More Good Report, which highlights performance and progress against goals set forth in the Do More Good Plan, the Company’s environmental, social, governance, plus sustainable solutions (or ESG+) strategy and roadmap that activates its purpose of applying science and creativity for a better world.

IFF (NYSEIFF) reported financial results for the first quarter ended March 31, 2023.

IFF (NYSEIFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.81 per share of its common stock, payable on July 11, 2023 to shareholders of record as of June 23, 2023.

IFF (NYSEIFF) today announced that it will release its first quarter 2023 earnings results following the market close on Monday, May 8, 2023. The management team will host a live webcast on Tuesday, May 9, 2023 at 9:00 a.m. ET to discuss results and outlook with the investor community.

IFF (NYSEIFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.81 per share of its common stock, payable on April 6, 2023 to shareholders of record as of March 24, 2023.

IFF (NYSEIFF) announced today that the Company’s management will speak at the Consumer Analyst Group of New York (CAGNY) conference in Boca Raton, Florida, on Thursday, Feb. 23 at 1:00 PM ET.

IFF (NYSEIFF) today outlined the recent changes to its Board of Directors, consistent with its plans to evolve its Board in line with best-in-class corporate governance standards, announced in connection with its long-term strategic and financial vision on Dec. 7, 2022.

IFF (NYSEIFF) today announced the appointment of Gary Hu to the Company’s Board of Directors, effective Feb. 1, 2023. Hu, a portfolio manager at Icahn Capital, will be appointed to the Board’s Audit and Transaction Committees. In connection with this appointment, IFF has entered into a cooperation agreement with Icahn Capital LP and its affiliates.

IFF (NYSEIFF) today announced the appointment of accomplished consumer products industry executive Dawn Willoughby to the Company’s Board of Directors as an independent director, effective Feb. 1, 2023. Willoughby, who most recently served as executive vice president and chief operating officer of The Clorox Company, brings an impressive track record of driving sustainable, profitable growth with a focus on innovation and sustainability for global consumer businesses.

IFF (NYSEIFF) today announced that it will release its fourth quarter & full year 2022 earnings results following the market close on Wednesday, Feb 8, 2023. The management team will host a live webcast on Thursday, Feb. 9, 2023 at 9:00 a.m. ET to discuss results and outlook with the investor community.

IFF (NYSEIFF) today announced it has qualified for the third consecutive year as a constituent of the Dow Jones Sustainability Indices (DJSI), a family of benchmarks widely regarded as one of the world’s leading tools for investors to integrate sustainability considerations into their portfolios to increase long-term shareholder value. Named to both the 2022 World Index and the North America Index, IFF is the only company in its industry to be included.

Philippe Horvath—renowned molecular biologist and IFF technical fellow—is being inducted into the National Inventors Hall of Fame® Class of 2023. Horvath will be formally honored for two patents related to CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) sequences and associated Cas proteins, that constitute an acquired immune system in bacteria. Applying this research to enhance starter cultures in the dairy industry, Horvath and research partner Rodolphe Barrangou improved the world’s food supply and laid the foundation for the field of gene editing. The formal induction will take place during a ceremony in October 2023 in Washington, D.C.

IFF (NYSEIFF) today announced it has entered into an agreement to sell its Savory Solutions Group to PAI Partners, a leading global private equity firm with a strong focus on the food and consumer industry. The transaction values the business at approximately $900 million and cash proceeds net of taxes and expenses will be primarily used to reduce outstanding debt.

IFF (NYSEIFF) has named Sabrya Meflah President of its Fine Fragrance business unit, effective immediately. Meflah—who is currently vice president and regional general manager, Europe, Middle East, Africa (EMEA)—succeeds Dionisio Ferenc. In her new role, she will oversee strategy and growth of IFF’s Fine Fragrance business unit.

IFF (NYSEIFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.81 per share of its common stock, payable on January 6, 2023 to shareholders of record as of December 28, 2022.

IFF (NYSEIFF) today announced that Nicolas Mirzayantz, president of IFF’s Nourish division, will leave the Company following a successful 34+ year tenure, effective Dec. 31, 2022. Upon his departure, IFF CEO Frank Clyburn will lead IFF’s current Nourish division until a replacement is named.

IFF (NYSEIFF) today announced the next phase of its strategic transformation by previewing its refreshed strategic plan and new operating model, developed through an extensive assessment with the Company’s senior leadership, customers, investors and key partners.

IFF (NYSEIFF) has named Dennis Maroney Master Perfumer, an honor recognizing his career achievements, entrepreneurial contributions and record of commercial excellence in the global perfumery industry. Maroney is a 32-year industry veteran and IFF’s ninth Master Perfumer, a distinction reserved for those who have demonstrated exceptional leadership and measurable impact in perfumery.

IFF (NYSEIFF) today announced that it will webcast its 2022 Investor Day presentation on Wednesday, Dec. 7, 2022, beginning at 1:00 p.m. ET.

IFF (NYSEIFF) reported financial results for the third quarter ended September 30, 2022.

Today in a ceremonial presentation, IFF (NYSEIFF) and Florida Polytechnic University laid the foundation for the new Citrus Innovation Center, located on the University’s campus in Lakeland, Florida. The nearly 30,000-square-foot, standalone building will support global citrus research and development, and will include sensory and experience venues, research labs, processing, analytical departments, a fully equipped citrus garden and amenities for hosting customers and partners.

IFF (NYSEIFF) today announced that it will release its third quarter 2022 earnings results following the market close on Monday, Nov. 7, 2022. The management team will host a live webcast on Tuesday, Nov. 8, 2022 at 9:00 a.m. ET to discuss results and outlook with the investor community.

IFF (NYSEIFF) today announced that Ralf Finzel has been named executive vice president and global operations officer, effective Nov. 1, 2022. He succeeds Francisco Fortanet, who will be leaving the Company following a period of transition. With this appointment, Finzel becomes a member of IFF’s Executive Committee and will be based in the Company’s New York City headquarters.

IFF (NYSEIFF) today announced the opening of its new Singapore Innovation Center, the first in its global network of research, creative and application centers to integrate the technologies, capabilities and expertise of all four business divisions: Nourish, Health & Biosciences, Scent and Pharma Solutions. At nearly 11,000 square meters, it is IFF’s largest in the region.

IFF (NYSEIFF) today announced that Deborah Borg will join the Company as Executive Vice President, Chief Human Resources and Diversity & Inclusion Officer, effective August 29, 2022. Peter Sommers—currently Interim Chief Human Resources Officer—will resume the position of VP, Global People Services and support Borg for a seamless transition.

IFF (NYSEIFF) today announced that it will release its second quarter 2022 earnings results following the market close on Monday, August 8, 2022. The management team will host a live webcast on Tuesday, August 9, 2022 at 9:00 a.m. ET to discuss results and outlook with the investor community.

IFF (NYSEIFF) today announced that it has successfully completed the previously announced divestiture of its Microbial Control business unit to LANXESS.

IFF (NYSEIFF) has released its 2021 environmental, social and governance plus sustainable solutions (or ESG+) performance report. Published today, “Transforming Our World,” details the Company’s commitment to do more good for people and the planet, aligned with IFF’s purpose—Applying science and creativity for a better world. Centered around the recently launched Do More Good Plan, the report updates progress on legacy IFF targets, looks ahead to even more ambitious 2030 objectives, and aims to address the world’s most pressing sustainable development challenges from IFF’s perspective.

IFF (NYSEIFF) today announced that Chief Executive Officer Frank Clyburn will participate in a fireside chat at the Bernstein 2022 Strategic Decisions Conference on Wednesday, June 1, 2022 at 8 am ET.

IFF (NYSEIFF) announced that its Board of Directors has declared a regular quarterly cash dividend of $0.79 per share of its common stock, payable on July 6, 2022 to shareholders of record as of June 24, 2022.

IFF (NYSEIFF) today announced that it will release its first quarter 2022 earnings results following the market close on Monday, May 9, 2022. The management team will host a live webcast on Tuesday, May 10, 2022 at 9:00 a.m. ET to discuss results and outlook with the investor community.

IFF (NYSEIFF) today announced that it has completed the previously announced acquisition of Health Wright Products, LLC (HWP), a leader in formulation and capsule manufacturing for the dietary supplement industry and a long-time business partner of IFF’s Health & Biosciences probiotics business.

IFF (NYSEIFF) today announced that Susana Suarez Gonzalez, PhD, Executive Vice President, Chief Human Resources and Diversity & Inclusion Officer, will be leaving the company, and Peter Sommers, current VP, Global People Services, has been appointed as Interim Chief Human Resources Officer. Dr. Suarez Gonzalez intends to remain with the company to assist through a transition period.

IFF (NYSEIFF) today announced that it has entered into an agreement to acquire Health Wright Products, LLC (HWP), a leader in formulation and capsule manufacturing for the dietary supplement industry.

IFF (NYSEIFF) announced today that Executive Vice President and Chief Financial Officer Glenn Richter will be a featured speaker at the Consumer Analyst Group of New York's annual conference, to be held virtually on Thursday, Feb. 24, 2022. A pre-recorded webcast of his presentation is scheduled to begin at 3:00 p.m. ET. Following the session, a replay will be accessible at ir.iff.com.

IFF (NYSEIFF) today announced the appointment of Barry A. Bruno to the Company’s Board of Directors as an independent director, effective February 8, 2022.

IFF (NYSEIFF) today announced that it will release its fourth quarter and full year 2021 earnings results following the market close on Wednesday, February 9, 2022. The management team will host a live webcast on Thursday, February 10, 2022 at 9:00 a.m. ET to discuss results and outlook with the investor community.

IFF (NYSEIFF) today announced the appointment of Frank Clyburn, an accomplished leader and operational executive, to succeed Andreas Fibig as Chief Executive Officer and a member of the IFF Board of Directors, effective February 14, 2022.